Glen Santangelo
Stock Analyst at Jefferies
(2.19)
# 1,235
Out of 4,641 analysts
72
Total ratings
45.45%
Success rate
-3.98%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $17.38 | +3.57% | 2 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $15.86 | +51.32% | 4 | Sep 19, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $10 | $8.68 | +15.21% | 6 | Sep 17, 2024 | |
| VTRS Viatris | Reinstates: Buy | $15 | $11.55 | +29.87% | 3 | Jul 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $21.38 | +7.58% | 4 | Jun 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Buy | $19 → $23 | $18.41 | +24.93% | 4 | Jun 27, 2024 | |
| COLL Collegium Pharmaceutical | Upgrades: Buy | $41 → $44 | $35.89 | +22.60% | 3 | Jun 7, 2024 | |
| ELAN Elanco Animal Health | Initiates: Buy | $17 | $12.51 | +35.89% | 1 | Dec 19, 2023 | |
| ZTS Zoetis | Assumes: Buy | $230 | $188.99 | +21.70% | 1 | Dec 19, 2023 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Buy | $10 | $1.51 | +562.25% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $49.83 | +40.48% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $14 | $3.20 | +337.50% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5.5 | $0.67 | +720.90% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $3.11 | +28.62% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $16.33 | -2.02% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $4.37 | +220.37% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $0.77 | +547.17% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $41.42 | +11.06% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $87.61 | -8.69% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $8.08 | +246.53% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $18.40 | +280.43% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $9.97 | +1,103.61% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.75 | -27.27% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $6.54 | +618.65% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $14.24 | +96.63% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.30 | +737.21% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $56.78 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $501.76 | -66.32% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $21.21 | - | 2 | Jan 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $111.92 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $70.22 | +16.78% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $24.01 | +237.36% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $207.66 | +20.39% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $9.35 | +734.22% | 1 | Dec 4, 2017 |
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $17.38
Upside: +3.57%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $15.86
Upside: +51.32%
Teladoc Health
Sep 17, 2024
Maintains: Hold
Price Target: $8 → $10
Current: $8.68
Upside: +15.21%
Viatris
Jul 19, 2024
Reinstates: Buy
Price Target: $15
Current: $11.55
Upside: +29.87%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $21.38
Upside: +7.58%
Teva Pharmaceutical
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $18.41
Upside: +24.93%
Collegium Pharmaceutical
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $35.89
Upside: +22.60%
Elanco Animal Health
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $12.51
Upside: +35.89%
Zoetis
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $188.99
Upside: +21.70%
Verrica Pharmaceuticals
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $49.83
Upside: +40.48%
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $3.20
Upside: +337.50%
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.67
Upside: +720.90%
Oct 21, 2022
Assumes: Buy
Price Target: $4
Current: $3.11
Upside: +28.62%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $16.33
Upside: -2.02%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $4.37
Upside: +220.37%
Oct 21, 2022
Assumes: Buy
Price Target: $5
Current: $0.77
Upside: +547.17%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $41.42
Upside: +11.06%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $87.61
Upside: -8.69%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $8.08
Upside: +246.53%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $18.40
Upside: +280.43%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $9.97
Upside: +1,103.61%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.75
Upside: -27.27%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $6.54
Upside: +618.65%
Dec 2, 2021
Initiates: Buy
Price Target: $28
Current: $14.24
Upside: +96.63%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.30
Upside: +737.21%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $56.78
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $501.76
Upside: -66.32%
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $21.21
Upside: -
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $111.92
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $70.22
Upside: +16.78%
Dec 8, 2017
Initiates: Buy
Price Target: $81
Current: $24.01
Upside: +237.36%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $207.66
Upside: +20.39%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $9.35
Upside: +734.22%